Jianguo Q. Sun
Xinqiao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
An explainable attention-gated stacking ensemble model for predicting survival in non-small cell lung cancer: development and validation.
Journal: Journal of thoracic disease
Published: March 28, 2026
An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in Rat.
Journal: Drug design, development and therapy
Published: January 19, 2026
Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics.
Journal: Asia-Pacific journal of clinical oncology
Published: January 07, 2026
An LC-MS/MS-Based Quantification of Intracellular Anlotinib Reveals Exposure-Toxicity Relationships in Endothelial and Intestinal Epithelial Cells.
Journal: Biomedical chromatography : BMC
Published: December 16, 2025
Deep and High-Throughput Proteomic Atlas of Chinese Bovine Colostrum Reveals Regional Signatures.
Journal: Journal of dairy science
Published: November 28, 2025
Deacetyl Ophiopojaponin A ameliorates Asthma by Inhibiting L-Type Calcium Channel Cav2.3 to Reduce Calcium Load in Airway Epithelial Cells.
Journal: Journal of inflammation research
Published: November 13, 2025
Tumor-Derived Exosomes Deliver Membrane-Bound Fgl2 to Activate FcγRIIB-Mediated Immunosuppression in Myeloid-Derived Suppressor Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 30, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy.
Journal: Journal of hematology & oncology
Published: August 04, 2025
Transcriptomic comparison of human intestinal organoids and Caco-2 cells in modeling nutrient absorption: insights from infant formula and breast milk.
Journal: NPJ science of food
Published: July 12, 2025
MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 24, 2025
A Case Report of Primary Pulmonary Lymphoepithelioma-Like Carcinoma with "Harmful" Pseudoprogression and a Pathological Complete Response (pCR) after Immunotherapy Plus Radiotherapy.
Journal: Oncology research
Published: May 25, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH).
Journal: International journal of radiation oncology, biology, physics
Published: January 21, 2025
Last Updated: 09/26/2026